Entities / Company
Ironwood Pharmaceuticals.
company in Cambridge, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 27
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Ironwood Pharmaceuticals and Guardian Pharmacy Services, Inc. are medical companies whose stock price volatility is being monitored against the S&P 500 market index.Some support4 reports
-
Ironwood Pharmaceuticals was classified in the Zacks Medical - Drugs industry in August 2025.Some support1 report
-
Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Ironwood Pharmaceuticals this week
News at the entities that move Ironwood Pharmaceuticals most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Ironwood Pharmaceuticals
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Ironwood Pharmaceuticals
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Ironwood Pharmaceuticals
-
Jefferies Financial Group Mentioned togetherJefferies reaffirmed Amazon's stock buy rating on June 18, 2026.Moves Ironwood Pharmaceuticals
-
AbbVie Mentioned togetherAbbVie and Cerevel Therapeutics successfully launched a new drug for Parkinson's disease, pending government coverage negotiations.Moves Ironwood Pharmaceuticals
-
AstraZeneca Mentioned togetherAstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Moves Ironwood Pharmaceuticals
Connections
The 6 strongest of 27, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA mandates specific clinical trial requirements and design alignment for Ironwood Pharmaceuticals' drug development.
-
SEC Structural
Ironwood Pharmaceuticals is subject to SEC regulations requiring disclosure of insider trading transactions.
-
Nasdaq Structural
Ironwood Pharmaceuticals is listed on the Nasdaq electronic stock exchange.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provided an analyst rating upgrade to 'hold' for Ironwood Pharmaceuticals.
-
AbbVie Mentioned together
No direct coupling or interaction between AbbVie and Ironwood Pharmaceuticals was observed in the provided evidence.
-
AstraZeneca Mentioned together
No direct relationship between Ironwood Pharmaceuticals and AstraZeneca was observed in the provided evidence.
History
Events by the month they beganSeptember 2026
2 eventsJuly 2026
1 eventJune 2026
3 events- Ironwood Pharmaceuticals and Guardian Pharmacy Services, Inc. are medical companies whose stock price volatility is being monitored against the S&P 500 market index.
- Ironwood Pharmaceuticals was classified in the Zacks Medical - Drugs industry in August 2025.
- Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.